$269,952,453
to GLOBAL HEALTH INVESTMENT CORPORATION
OTHER TRANSACTION AGREEMENT: BARDA VENTURES
Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.
What the model surfaced from this award
An obligation under BARDA's venture investment program to support biotech companies developing medical countermeasures for pandemic preparedness, begun in 2021.
BARDA Ventures accelerates private-sector innovation in vaccines and therapeutics critical to U.S. biosecurity and pandemic response capacity.
Strengthens domestic biotech manufacturing and R&D ecosystems by channeling federal capital to early-stage companies developing platform technologies for rapid response.
Positions U.S. biotech firms to lead in rapid vaccine and therapeutic development, reducing dependence on foreign supply chains during health emergencies.
Generated by award_classification v2.1.0 via claude-haiku-4-5-20251001 on 2026-05-19. Cost: $0.003030.
- USAspending.gov — all awards for this UEI →
- SAM.gov entity registration →
- Award record ingested from usaspending. Source identifier CONT_AWD_75A50121C00020_7505_-NONE-_-NONE-.
The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.